Results 51 to 60 of about 3,671 (210)

asda

dad
  +6 more sources

Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study

Arthritis Research & Therapy, 2023
Background Upadacitinib (UPA) is a selective JAK inhibitor recently approved for the treatment of psoriatic arthritis (PsA). In this post-approval study, we aimed to evaluate the effectiveness and safety of UPA over 24 weeks and identify clinical ...
Michele Maria Luchetti Gentiloni, Valentino Paci, Antonio Carletto, Alen Zabotti, Roberta Ramonda, Maria Sole Chimenti, Lorenzo Dagna, Nicoletta Luciano, Anna Piccinelli, Ivan Giovannini, Giovanni Striani, Nicola Boffini, Gilda Sandri, Niccolò Possemato, Ilenia Pantano, Devis Benfaremo, Carlo Salvarani, Francesco Ciccia, Carlo Selmi, Gianluca Moroncini   +19 more
doaj   +1 more source

From Cosmetic Standards to Circular Value: A Systematic Review of Business Strategies for Suboptimal Foods

Business Strategy and the Environment, EarlyView.
ABSTRACT Suboptimal foods, that is, safe and nutritious products that deviate from market standards because of cosmetic defects, packaging damage, or proximity to date labels, constitute a major source of avoidable food waste. Evidence on how firms can reduce this waste and capture value still remains fragmented across disciplines and supply‐chain ...
Marilena Gemtou, Stelios Tsafarakis, Spyros Fountas   +2 more
wiley   +1 more source

sj-docx-1-tab-10.1177_1759720X221085951 – Supplemental material for Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study

, 2022
Supplemental material, sj-docx-1-tab-10.1177_1759720X221085951 for Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study by Fabian Proft, Julia Schally, Henning ...
Fabian Proft (10091897), Henriette Käding (12323678), Susanne Lüders (12323681), Maryna Verba (12323690), Julia Schally (12323666), Jan Brandt-Juergens (12323672), Kirsten Karberg (11629513), Denis Poddubnyy (4963726), Henning Christian Brandt (12323669), Hildrun Haibel (9363403), Silke Zinke (3558698), Judith Rademacher (12323684), Murat Torgutalp (6485072), Burkhard Muche (346191), Gerd Rüdiger Burmester (12323675), Valeria Rios Rodriguez (12323687), Mikhail Protopopov (10091903)   +16 more
core   +1 more source

Magnetic resonance tomography capabilities and limitations in managing the efficacy of treatment with biological disease modifying anti-rheumatic drugs in ankylosing spondylitis

Современная ревматология, 2021
Extensive use of magnetic resonance imaging (MRI) in clinical practice revolutionized our understanding of the pathogenesis of axis spondyloarthritis (aSpA) and treatment approaches.
P. A. Shesternya, O. D. Gritsenko, P. A. Astanin, A. Yu. Stepanenko, N. V. Popov   +4 more
doaj   +1 more source

Establishing Safe and Consistent Moderate Intravenous (IV) Sedation Practices in Dental Education: A Protocol‐Based Approach

Journal of Dental Education, EarlyView.
ABSTRACT Objective Moderate IV sedation is increasingly essential in contemporary dental practice, yet significant variability exists in how dental institutions teach, supervise, and regulate its use. This perspective outlines a protocol‐based framework designed to improve patient selection, safety, and instructional consistency in an academic setting.
Christopher M. Lee, Steve Nguyen, Casey S. Kim, Patrick Choi   +3 more
wiley   +1 more source

Exploratory MRI and Clinical Marker Analysis of Pustulotic Arthro‐Osteitis Disease Activity From a Phase 3 Brodalumab Trial

The Journal of Dermatology, EarlyView.
ABSTRACT Pustulotic arthro‐osteitis (PAO) is a clinically important osteoarticular comorbidity affecting approximately 9%–28% of patients with palmoplantar pustulosis (PPP), yet early recognition and standardized activity assessment remain challenging, particularly in routine dermatology practice.
Taiki Nozaki, Manabu Arai, Junko Ochi, Mona Uchida‐Yamada, Masahiro Hashimoto, Mitsuhiro Akiyama, Yuko Kaneko, Yasumasa Kanai, Masahiro Jinzaki   +8 more
wiley   +1 more source

Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: A cohort study

, 2015
The aim of this study was to assess discriminant validity of Ankylosing Spondylitis Disease Activity Score (ASDAS)-C-reactive protein (-CRP) and ASDAS-erythrocyte sedimentation rate (-ESR) and to compare with The Bath Ankylosing Spondylitis Disease ...
Kilic E., Akgul O., Kilic G., Ozgocmen S.   +3 more
core   +2 more sources

Understanding Employer Brand Attractiveness Through Regulatory Focus Theory

Psychology &Marketing, Volume 43, Issue 10, Page 2735-2746, October 2026.
ABSTRACT The aim of this paper is to understand the mechanism behind potential employees' preferences towards specific employer brand attributes. Drawing on qualitative data and regulatory focus theory, the paper presents a framework which shows that the dominant regulatory orientation of potential employees determines their preference towards specific
Carmen Iuliana Mal, Gary Davies
wiley   +1 more source

How to calculate the ASDAS based on C-reactive protein without individual questions from the BASDAI: the BASDAI-based ASDAS formula.

, 2019
To develop a new equation to calculate the Ankylosing Spondylitis Disease Activity Score based on CRP (ASDAS-CRP) using only the BASDAI total score and CRP. Axial SpA (axSpA) patients from the Cordoba Spondyloarthritis Registry cohort were recruited as a
Vazquez-Mellado, Janitzia, Juanola, Xavier, Gonzalez-Navas, Cristina, Font-Ugalde, Pilar, Castro-Villegas, M Carmen, Ladehesa-Pineda, Lourdes, Aranda-Valera, I Concepcion, Garrido-Castro, Juan L, Zarco, Pedro   +8 more
core   +1 more source